Reliance Pharma Fund (G)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 544.00
NAV 15 Dec 2017 138.77 0.30
(0.22%)

NAV High-Low (in Rs)

ONE Mth 1794.40
1794.40
52-WEEk 1235.15
1794.40

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - 4.17 7.87 - 3.82
Sensex 0.44 1.49 8.2 26.85 23.87
Nifty 0.64 1.7 8.35 27.63 27.32

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 544.00 (31 Dec 10)
Inception Date 10 May 04
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 30 Nov 2017
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 2.20
Derivatives 0.80
Equity 98.72
› More
   As On 30 Nov 2017
Sector Name Amount
Finance & Investments 2.19
Healthcare 12.81
NA 3.00
Pharmaceuticals - Indian - Bulk Drugs 15.47
Pharmaceuticals - Indian - Bulk Drugs & Formln 51.05
Pharmaceuticals - Multinational 17.20
› More
   As On 30 Nov 2017
Company Name
Divi's Lab. 11.60
Abbott India 9.71
Cipla 8.71
Sun Pharma.Inds. 8.58
Dr Reddy's Labs 8.54
Biocon 8.17
Aurobindo Pharma 7.72
Sanofi India 7.49
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com